Cargando…
Low level of the plasma sphingolipid, glucosylceramide, is associated with thrombotic diseases
ESSENTIALS: Minor abundance plasma lipids, eg, glucosylceramide, can modulate blood coagulation reactions. This lipid was measured in plasmas of 1 myocardial infarction and 2 venous thrombosis populations. Low plasma glucosylceramide levels were found in each population compared to matched controls....
Autores principales: | Deguchi, Hiroshi, Navarro, Silvia, Payne, Amanda B., Elias, Darlene J., Dowling, Nicole F., Austin, Harland D., España, Francisco, Medina, Pilar, Hooper, W. Craig, Griffin, John H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703432/ https://www.ncbi.nlm.nih.gov/pubmed/29202121 http://dx.doi.org/10.1002/rth2.12018 |
Ejemplares similares
-
Amyotrophic lateral sclerosis and denervation alter sphingolipids and up-regulate glucosylceramide synthase
por: Henriques, Alexandre, et al.
Publicado: (2015) -
Are Glucosylceramide-Related Sphingolipids Involved in the Increased Risk for Cancer in Gaucher Disease Patients? Review and Hypotheses
por: Dubot, Patricia, et al.
Publicado: (2020) -
Minor plasma lipids modulate clotting factor activities and may affect thrombosis risk
por: Deguchi, Hiroshi, et al.
Publicado: (2017) -
Enhancement of human plasma glucosylceramide assay sensitivity using delipidized plasma
por: Zheng, Kefei, et al.
Publicado: (2016) -
Glycosphingolipid Changes in Plasma in Parkinson's Disease Independent of Glucosylceramide Levels
por: te Vruchte, Danielle, et al.
Publicado: (2022)